U-NWBO

Q:NWBO - NORTHWEST BIOTHERAPEUTICS INC - https://www.nwbio.com/

04:34:24 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
NWBO - Q	not subscribed					0.164	-0.001	-0.6	1,261.0	198	190	0.1643 0.1675 0.16	0.368 0.1411	15:58:24	Jul 08	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
OTC Markets Indicators -- Primary Market: OTC Markets -- Tier: OTCQB -- Status: Active

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Portfolio

Recent Trades - Last 10 of 190

More trades...

Time ET	Ex	Price	Change	Volume
15:58:24	Q	0.164	-0.001	175
15:57:56	Q	0.162	-0.003	266
15:57:38	Q	0.1629	-0.0021	15,000
15:57:14	Q	0.164	-0.001	444
15:56:01	Q	0.162	-0.003	10,000
15:54:14	Q	0.163	-0.002	30
15:54:14	Q	0.1639	-0.0011	30
15:51:36	Q	0.162	-0.003	16,560
15:51:23	Q	0.162	-0.003	8,900
15:51:23	Q	0.162	-0.003	5,000

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2026-07-08 14:24	U:NWBO	News Release200	Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of DCVax(TM)-L For Glioblastoma Using Individual Patient Level Data in Multiple Independent Analyses
2026-07-02 14:17	U:NWBO	News Release200	Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the British Neuro-Oncology Society Annual Meeting
2026-06-01 08:30	U:NWBO	News Release200	How Advanced Drug Delivery Could Improve Existing Cancer Treatments
2026-05-11 08:30	U:NWBO	News Release200	CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
2026-04-30 12:30	U:NWBO	News Release200	Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform
2026-04-21 09:30	U:NWBO	News Release200	Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic
2025-11-20 14:40	U:NWBO	News Release200	Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility
2025-10-24 12:03	U:NWBO	News Release200	Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed
2025-08-27 12:39	U:NWBO	News Release200	Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.
2025-08-18 12:37	U:NWBO	News Release200	Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman

Date ET

Symbol

Type

Headline

2026-07-08 14:24

U:NWBO

News Release

Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of DCVax(TM)-L For Glioblastoma Using Individual Patient Level Data in Multiple Independent Analyses

2026-07-02 14:17

U:NWBO

News Release

Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the British Neuro-Oncology Society Annual Meeting